
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter D - Drugs for Human Use
#### PART 312 - INVESTIGATIONAL NEW DRUG APPLICATION
##### Subpart A - General Provisions
###### ยง 312.2 Applicability.
####### a,b,c

(ii) In accordance with paragraph (b)(2)(i) of this section, the following products are exempt from the requirements of this part: () blood grouping serum; () reagent red blood cells; and () anti-human globulin.

(3) A drug intended solely for tests in vitro or in laboratory research animals is exempt from the requirements of this part if shipped in accordance with ยง 312.160.

(4) FDA will not accept an application for an investigation that is exempt under the provisions of paragraph (b)(1) of this section.

(5) A clinical investigation involving use of a placebo is exempt from the requirements of this part if the investigation does not otherwise require submission of an IND.

(6) A clinical investigation involving an exception from informed consent under ยง 50.24 of this chapter is not exempt from the requirements of this part.
